Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

CRISM' Therapeutics Corp

CRTX.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Pharmaceuticals ·

UK Micro Cap Analyst: N/A

Last Close

$0.15

▲ +0.00%

Market Cap $11.48M · Vol 511.50K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$11.48M

Micro Cap

Div Yield

N/A

Dividend with no set frequency

EPS Growth

N/A

YoY

RSI (14)

100.00

Momentum

Beta

1.54

vs Market

52W High

$0.25

41.60% below

52W Low

$0.11

36.29% above

Volume

511.50K

Avg 374.34K

P/B

3.65

Price-to-book

ROE

N/A

Return on equity

Free Float

67.33%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, CRISM' Therapeutics Corp (CRTX.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CRTX.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+13.16%

+7.50%

-10.42%

-20.37%

YTD

+7.50%

+2.38%

-42.75%

+76.81%

Financials & Valuation

TTM · Annual

Total Revenue	$311.22K
Net Income	$-2,532,908.00
Revenue Growth (YoY)	+824.00%
Gross Margin	56.71%
Operating Margin	-812.99%
Net Profit Margin	-813.85%
ROE	N/A
ROA · ROIC	-103.96% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	15.79
P/B	3.65
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	79.19M

Technical Indicators

50-Day SMA	$0.14
200-Day SMA	$0.15
RSI (14)	100.00
Beta	1.54
52-Week High	$0.25
52-Week Low	$0.11

Volume Today	511.50K
Avg Daily Volume (30D)	374.34K
Relative Volume	1.37x
Volatility (10D)	39.79
Volatility (30D)	34.04
Free Float	67.33%

Analyst Consensus

N/A

Current Price $0.15

Mean Target N/A

52W Low$0.11 52W High$0.25

Current

Target

$0.11 $0.25

Current Analyst target

· 0 analysts

Identifiers

ExchangeLSE

FIGIBBG001SN9TR4

ISINVGG042401262

CountryVirgin Islands; British

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

CRISM Therapeutics Corporation, formerly Amur Minerals Corporation, is a British Virgin Islands-based pharmaceutical company. The Company has developed a drug delivery technology, ChemoSeed, to improve the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy. Its lead product, ChemoSeed, is a polymer the size of a grain of rice, administering irinotecan, a generic drug approved to treat brain cancer and can be implanted directly into a tumor or the resection margin following the removal of a tumor, thereby ensuring that effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. It seeks to use ChemoSeed to treat high grade gliomas, a brain tumor with no satisfactory treatment. The Company also offers formulation and consultancy services. It provides assistance and services to improve the bioavailability of poorly soluble drugs. It offers remixers and extruders of various sizes.